derinet® Switzerland
Product names from:
VontobelSVSP
Back

Express VONCERT on AbbVie Inc, Bristol-Myers Squibb, Fresenius & KGaA, Gilead Sciences (Quanto CHF)

  • Valor 46468769
  • ISIN CH0464687695
  • Symbol
sustainable
Bid (indicative)%
Ask (indicative)
CurrencyCHF
Price on
  • Quanto
  • Barrier observation at the end
  • Autocallable
  • sustainable
AbbVie IncUSD 
Bristol-Myers Squibb Co.USD 
Fresenius SE & Co. KGaAEUR 
Gilead Sciences Inc.USD 
Please note that this is an indication.

Documents

Life cycle
Initial fixing11/03/2019
Payment date18/03/2019
Last trading day11/09/2020
Final fixing11/09/2020
Redemption18/09/2020

Current price information

Intraday1 week1 monthSince emission
until

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrier
USD 70.27USD 62.28USD 50.60
USD 44.19USD 40.81USD 33.16
EUR 46.80EUR 38.40EUR 31.20
USD 68.07USD 51.23USD 41.63

No chart available

Life cycle
Initial fixing11/03/2019
Payment date18/03/2019
Last trading day11/09/2020
Final fixing11/09/2020
Redemption18/09/2020
Figures
Product typeExpress VONCERT
SSPA categorisationExpress Certificate
Issue price100.00%
Reference currencyCHF
QuantoYes
BarrierUSD 50.60
Barrier observationat the end
Underlying/
ISIN of underlying
AbbVie Inc
US00287Y1091
Spot reference priceUSD 77.85
COSINo
ListingNone
Additional conditions
IssuerVontobel Financial Products Ltd., DIFC Dubai
GuarantorVontobel Holding AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliveryphysical delivery
Issuance ProgrammeLink to the Issuance Program